1. Home
  2. ESPR vs PD Comparison

ESPR vs PD Comparison

Compare ESPR & PD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.19

Market Cap

816.9M

Sector

Health Care

ML Signal

HOLD

Logo PagerDuty Inc.

PD

PagerDuty Inc.

HOLD

Current Price

$10.86

Market Cap

782.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
PD
Founded
2008
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
816.9M
782.0M
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
ESPR
PD
Price
$3.19
$10.86
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$8.75
$12.63
AVG Volume (30 Days)
16.8M
2.0M
Earning Date
05-07-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
60.71
416.95
EPS
N/A
0.13
Revenue
$403,135,000.00
$492,546,000.00
Revenue This Year
N/A
$3.58
Revenue Next Year
$12.81
$2.88
P/E Ratio
N/A
$84.81
Revenue Growth
21.31
5.36
52 Week Low
$1.11
$5.70
52 Week High
$4.18
$17.45

Technical Indicators

Market Signals
Indicator
ESPR
PD
Relative Strength Index (RSI) 67.43 67.72
Support Level $3.16 $6.08
Resistance Level $3.26 $13.43
Average True Range (ATR) 0.02 0.58
MACD -0.01 0.09
Stochastic Oscillator 78.57 82.97

Price Performance

Historical Comparison
ESPR
PD

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the company derives a majority of its revenue from the United States and the rest from International markets.

Share on Social Networks: